OTCMKTS:PURE PURE Bioscience (PURE) Stock Price, News & Analysis → Discover How to Turn $10,000 into $1 Million (From Paradigm Press) (Ad) Free PURE Stock Alerts $0.07 0.00 (0.00%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$0.06▼$0.0750-Day Range$0.07▼$0.1052-Week Range$0.06▼$0.17Volume38,225 shsAverage Volume28,111 shsMarket Capitalization$7.27 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get PURE Bioscience alerts: Email Address Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… About PURE Bioscience Stock (OTCMKTS:PURE)PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.Read More PURE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PURE Stock News HeadlinesJune 9, 2024 | americanbankingnews.comComparing PURE Bioscience (OTCMKTS:PURE) and ARQ (NASDAQ:ARQ)May 6, 2024 | morningstar.comKeymed Biosciences Inc 02162May 6, 2024 | businesswire.comPURE Bioscience Appoints Darin Zehr to Board of DirectorsMay 6, 2024 | finance.yahoo.comMikra Announces Joint Product with Jose BautistaMay 2, 2024 | msn.comEXCLUSIVE: Former Sprint CEO Dan Hesse On Going From Cleaning Sewers To Leading Billion-Dollar Tech CompaniesApril 29, 2024 | finance.yahoo.comVedanta Biosciences to Present at Upcoming Investor ConferencesApril 15, 2024 | finance.yahoo.comPURE Bioscience, Inc. (PURE)March 28, 2024 | msn.comScientists say they're closer to reviving Mammoths. What could go wrong?March 23, 2024 | msn.comSam Altman's mission to increase human lifespan with a $180 million shipping container experiment at Retro BiosciencesMarch 18, 2024 | businesswire.comPURE Bioscience Reports Fiscal Second Quarter 2024 Financial ResultsMarch 14, 2024 | yahoo.comAs European dynamism gathers momentum, Elaia and partners double down with new deep tech fundMarch 13, 2024 | finanznachrichten.deKuros Biosciences AG: Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023March 13, 2024 | markets.businessinsider.comKuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023March 7, 2024 | finance.yahoo.comMoligo Technologies Appoints John Kuijpers as Chief Business OfficerMarch 6, 2024 | finance.yahoo.comVedanta Biosciences to Host Investor Meetings at the Leerink Partners 2024 Global Biopharma ConferenceMarch 5, 2024 | finanznachrichten.deLexaria Bioscience Corp.: Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1March 1, 2024 | thetimes.co.ukThe world’s most expensive honey and the sweet taste of successFebruary 29, 2024 | marketwatch.comAvidity Biosciences Shares Climb on $400 Million Private PlacementFebruary 22, 2024 | news.yahoo.comMajor economic growth legislation could lift acre limit and attract billion dollar companiesFebruary 22, 2024 | benzinga.comPURE Bioscience Stock (OTC:PURE), Analyst Ratings, Price Targets, PredictionsFebruary 22, 2024 | sg.finance.yahoo.comQ4 2023 Arcus Biosciences Inc Earnings CallFebruary 20, 2024 | finance.yahoo.comWILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTSFebruary 7, 2024 | msn.comCell Microsystems and OMNI Life Science Announce Strategic Partnership to Bring Innovative Cellular Analysis Solutions to North AmericaFebruary 6, 2024 | finance.yahoo.comNightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open TodayFebruary 1, 2024 | markets.businessinsider.comNightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating OfficerSee More Headlines Receive PURE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/14/2024Today6/16/2024Fiscal Year End7/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Miscellaneous chemical products Sub-IndustryN/A Current SymbolOTCMKTS:PURE CUSIPN/A CIK1006028 Webwww.purebio.com Phone(619) 596-8600Fax619-596-8790Employees11Year Founded1992Profitability EPS (Most Recent Fiscal Year)($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,960,000.00 Net Margins-194.80% Pretax Margin-124.61% Return on Equity-717.03% Return on Assets-326.30% Debt Debt-to-Equity RatioN/A Current Ratio1.72 Quick Ratio1.59 Sales & Book Value Annual Sales$1.87 million Price / Sales3.89 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares111,860,000Free Float65,145,000Market Cap$7.27 million OptionableNot Optionable Beta0.12 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Robert F. Bartlett (Age 79)President, CEO & Director Comp: $129.8kMr. Mark Stuart Elliott (Age 49)VP of Finance and Principal Financial & Accounting Officer Comp: $180kMr. Thomas Richard Myers (Age 71)Executive VP of Technology & Development and Director Comp: $200kMr. Jeff KitchellVP of Operations & Corporate SecretaryMr. Tim SteffensmeierVice President of Sales & MarketingKey CompetitorsFlexible Solutions InternationalNYSE:FSIArtemis TherapeuticsOTCMKTS:ATMSHighCom Global SecurityOTCMKTS:HCGSEner-CoreOTCMKTS:ENCRGlyEcoOTCMKTS:GLYEView All Competitors PURE Stock Analysis - Frequently Asked Questions How have PURE shares performed in 2024? PURE Bioscience's stock was trading at $0.1297 at the start of the year. Since then, PURE stock has decreased by 49.9% and is now trading at $0.0650. View the best growth stocks for 2024 here. Are investors shorting PURE Bioscience? PURE Bioscience saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 37,300 shares, an increase of 532.2% from the May 15th total of 5,900 shares. Based on an average daily trading volume, of 37,300 shares, the days-to-cover ratio is currently 1.0 days. View PURE Bioscience's Short Interest. How were PURE Bioscience's earnings last quarter? PURE Bioscience, Inc. (OTCMKTS:PURE) announced its earnings results on Friday, June, 14th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.44 million for the quarter. PURE Bioscience had a negative net margin of 194.80% and a negative trailing twelve-month return on equity of 717.03%. What other stocks do shareholders of PURE Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other PURE Bioscience investors own include NVIDIA (NVDA), Boeing (BA), Overstock.com (OSTK), Pure Storage (PSTG), Riot Platforms (RIOT), Enphase Energy (ENPH), Mastercard (MA), Main Street Capital (MAIN), Twilio (TWLO) and How do I buy shares of PURE Bioscience? Shares of PURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PURE) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDouble-Threat Biotech Could Deliver Triple-Digit GainsMost investors haven't heard of this under-the-radar biotech... But it could emerge as one of the premier A...Behind the Markets | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PURE Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PURE Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.